Needham & Company Reiterates a 'Buy' on ESCO Technologies (ESE); In-Line F4Q. F12 Outlook Appears Steady Ahead Of Expectations For Strong F13
Get Alerts ESE Hot Sheet
Price: $308.01 +0.70%
Rating Summary:
9 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
9 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Needham & Company reiterates a 'Buy' on ESCO Technologies (NYSE: ESE) price target of $34.00.
Needham analyst says, "While the macro environment may be weighing on other names in our universe, ESE’s non-grid oriented business is performing well. Looking to the utility side of its business, Doble is exhibiting double-digit growth while Aclara sits in what we view as a very temporary pause ahead of the massive So Cal Gas ramp."
"Our Dec. est. now $154M revs. & $0.26 ($0.33 ex. amort.), vs. prior $167M & $0.48 (or, $0.56). Our F12 now $723M & $2.13 vs. prior $747M & $2.40. F13 est. is $838M & $2.82."
For an analyst ratings summary and ratings history on ESCO Technologies click here. For more ratings news on ESCO Technologies click here.
Shares of ESCO Technologies closed at $30.29 yesterday.
Needham analyst says, "While the macro environment may be weighing on other names in our universe, ESE’s non-grid oriented business is performing well. Looking to the utility side of its business, Doble is exhibiting double-digit growth while Aclara sits in what we view as a very temporary pause ahead of the massive So Cal Gas ramp."
"Our Dec. est. now $154M revs. & $0.26 ($0.33 ex. amort.), vs. prior $167M & $0.48 (or, $0.56). Our F12 now $723M & $2.13 vs. prior $747M & $2.40. F13 est. is $838M & $2.82."
For an analyst ratings summary and ratings history on ESCO Technologies click here. For more ratings news on ESCO Technologies click here.
Shares of ESCO Technologies closed at $30.29 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Coherent (COHR) PT Raised to $420 at Needham
- argenx SE (ARGX) PT Raised to $1,353 at TD Cowen
- Needham Starts Pulse Biosciences (PLSE) at Buy
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share